Applications: Biomedical
Our single-photon counting detectors participated in a groundbreaking research project on ultra-high pulse dose rate cancer radiotherapy. This innovative approach might dramatically reduce side effects while maintaining effective tumor control.
The World Health Organization estimates 4.2 million new cancer cases in Europe alone in 2018, with approximately half of the patients receiving radiotherapy. The so-called FLASH effect, observed when radiation doses are delivered quickly via a few ultra-high dose pulses, suggests the potential for more effective tumor control.
However, accurate dosimetry is crucial to ensure safety and effectiveness in radiotherapy, and this is where ADVACAM’s expertise plays an important role. We are focusing on developing methods for characterizing stray radiation, which could contribute to parasitic doses to healthy tissues outside the target volumes. Accurate measurement of this radiation is vital for therapy optimization and personalized dose management.
The research was conducted within the UHDpuse project in cooperation with prestigious international partners.
